RT @ueafam: #日本人 #治療抵抗性うつ病 患者における経口 #抗うつ薬 併用療法としての固定用量 #エスケタミン 鼻腔内噴霧剤の有効性と安全性:第2b相 #RCT 2021/10 @NagoyaUniv_info @JanssenGlobal 結論:〜 有効性は示せ…
132 followers
494 followers
RT @PloederlM: Interesting that the results of this (negative) Janssen 2b trial were made public after approving Esketamine by the FDA and…
5,432 followers
RT @PloederlM: @HengartnerMP @Fizzbw @johndrummond33 @psychgeist52 @Altostrata @jf_moore @markhoro And after approval, another grossly fail…
3,007 followers
@HengartnerMP @Fizzbw @johndrummond33 @psychgeist52 @Altostrata @jf_moore @markhoro And after approval, another grossly failed trial appeared. https://t.co/GTliNWix3S